CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Pre-funded warrant	Common Stock	Common Stock Pre-funded warrant	Additional Paid-In Capital	Additional Paid-In Capital Pre-funded warrant	Accumulated Other Comprehensive Gain/(Loss)	Accumulated Deficit
Beginning Balance at Dec. 31, 2022	$ 372,207		$ 5		$ 690,814		$ (679)	$ (317,933)
Beginning Balance, Shares at Dec. 31, 2022			48,877,806
Vesting of shares of common stock subject to repurchase	2				2
Vesting of shares of common stock subject to repurchase, Shares			395
Issuance of common stock upon exercise of stock options	1				1
Issuance of common stock upon exercise of stock options, Shares			253
Issuance of common stock upon vesting of restricted stock units, Shares			50,469
Issuance of common stock upon employee stock purchase plan	4,746				4,746
Unrealized gain (loss) on investments	505						505
Net loss	(30,815)							(30,815)
Ending Balance at Mar. 31, 2023	346,646		$ 5		695,563		(174)	(348,748)
Ending Balance, Shares at Mar. 31, 2023			48,928,923
Beginning Balance at Dec. 31, 2023	273,285		$ 5		708,706		8	(435,434)
Beginning Balance, Shares at Dec. 31, 2023			49,181,295
Issuance of common stock upon exercise of stock options	$ 578				578
Issuance of common stock upon exercise of stock options, Shares	128,671		128,671
Issuance of common stock, net of issuance costs		$ 225,073		$ 2		$ 225,071
Issuance of common stock, net of issuance costs, Shares			0	21,010,000
Issuance of common stock upon vesting of restricted stock units, Shares			133,595
Share-based compensation expense	$ 4,368				4,368
Unrealized gain (loss) on investments	(135)						(135)
Net loss	(29,518)							(29,518)
Ending Balance at Mar. 31, 2024	$ 473,651		$ 7		$ 938,723		$ (127)	$ (464,952)
Ending Balance, Shares at Mar. 31, 2024			70,453,561